European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Chimeric monoclonal antibody against GD2
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Chimeric monoclonal antibody against GD2
| EU orphan designation number: | EU/3/12/1062
|
| Active ingredient: | Chimeric monoclonal antibody against GD2 |
| Indication: | Treatment of neuroblastoma |
| Sponsor: | APEIRON Biologics AG
Campus Vienna Biocenter 5, A-1030 Wien, Österreich |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 12/11/2012 | Centralised Orphan - Designation | EMA/OD/112/12 | (2012)8195 of 08/11/2012 |